Emma Walkinshaw

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

Medicine, Endocrinology, Pharmacology +14

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text

Medicine, Endocrinology, Nephrology +15

Recovery of Hypoglycemia Awareness in Long-standing Type 1 Diabetes: A Multicenter 2 × 2 Factorial Randomized Controlled Trial Comparing Insulin Pump With Multiple Daily Injections and Continuous With Conventional Glucose Self-monitoring (HypoCOMPaSS)

Stuart Little, Lalantha Leelarathna, Emma Walkinshaw et al. · Diabetes Care · 2014 · 234 citations · Full text

Medicine, Internal Medicine, Diabetology +16

Home use of closed-loop insulin delivery for overnight glucose control in adults with type 1 diabetes: a 4-week, multicentre, randomised crossover study

Hood Thabit, Alexandra Lubina-Solomon, Marietta Stadler et al. · The Lancet Diabetes & Endocrinology · 2014 · 149 citations · Full text

Medicine, Endocrinology, Internal Medicine +17

Sustained Reduction in Severe Hypoglycemia in Adults With Type 1 Diabetes Complicated by Impaired Awareness of Hypoglycemia: Two-Year Follow-up in the HypoCOMPaSS Randomized Clinical Trial

Stuart Little, Jane Speight, Lalantha Leelarathna et al. · Diabetes Care · 2018 · 85 citations

Medicine, Internal Medicine, Diabetology +16